Einträge von van Rhijn, Bas W.G. auf dem Publikationsserver

van Ginkel, Noor , van Gennep, Erik J., Oosterbaan, Liselot, Greidanus, Joyce, Boellaard, Thierry N., Wondergem, Maurits, Vis, André N., de Reijke, Theo M., van Rhijn, Bas W.G. und Mertens, Laura S. (2023) Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy. Clinical Genitourinary Cancer 21 (3), S. 342-348. Volltext nicht vorhanden.

Gil-Jimenez, Alberto, van Dorp, Jeroen , Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. und van der Heijden, Michiel S. (2023) Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European Urology 83 (4), S. 313-317. Volltext nicht vorhanden.

Mertens, Laura S., Sharma, Vidit, Matin, Surena F., Boorjian, Stephen A., Houston Thompson, R., van Rhijn, Bas W.G. und Masson-Lecomte, Alexandra (2023) Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies. European Urology Open Science 49, S. 60-66. Volltext nicht vorhanden.

von Deimling, Markus, Mertens, Laura S., van Rhijn, Bas W.G., Lotan, Yair, Spiess, Philippe E., Daneshmand, Siamak, Black, Peter C., Pallauf, Maximilian, D'Andrea, David, Moschini, Marco, Soria, Francesco, Del Giudice, Francesco, Afferi, Luca, Laukhtina, Ekaterina, Yanagisawa, Takafumi, Kawada, Tatsushi, Teoh, Jeremy Y.-C., Abufaraj, Mohammad, Ploussard, Guillaume, Roumiguié, Mathieu, Karakiewicz, Pierre I., Babjuk, Marko, Gontero, Paolo, Xylinas, Evanguelos, Rink, Michael, Shariat, Shahrokh F. und Pradere, Benjamin (2023) Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer. European Urology Open Science 51, S. 39-46. Volltext nicht vorhanden.

Stokkel, Laura E., van Rossum, Huub H., van de Kamp, Maaike W., Boellaard, Thierry N., Bekers, Elise M., Kok, Niels F.M., van Rhijn, Bas W.G. und Mertens, Laura S. (2023) Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer. Urologic Oncology: Seminars and Original Investigations 41 (7), 326.e17-326.e24. Volltext nicht vorhanden.

Gil-Jimenez, Alberto, van Dorp, Jeroen, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. und van der Heijden, Michiel S. (2023) Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17]. European Urology 83 (6), e165. Volltext nicht vorhanden.

Sylvester, Richard J., Rodríguez, Oscar, Hernández, Virginia, Turturica, Diana, Bauerová, Lenka, Max Bruins, Harman, Bründl, Johannes, van der Kwast, Theo H., Brisuda, Antonin, Rubio-Briones, José, Seles, Maximilian, Hentschel, Anouk E., Kusuma, Venkata R.M., Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S., Volanis, Dimitrios, Cussenot, Olivier, Subiela Henríquez, Jose D., de la Peña, Enrique, Pisano, Francesca, Pešl, Michael, van der Heijden, Antoine G., Herdegen, Sonja, Zlotta, Alexandre R., Hacek, Jaromir, Calatrava, Ana, Mannweiler, Sebastian, Bosschieter, Judith, Ashabere, David, Haitel, Andrea, Côté, Jean-François, El Sheikh, Soha, Lunelli, Luca, Algaba, Ferran, Alemany, Isabel, Soria, Francesco, Runneboom, Willemien, Breyer, Johannes, Nieuwenhuijzen, Jakko A., Llorente, Carlos, Molinaro, Luca, Hulsbergen-van de Kaa, Christina A., Evert, Matthias, Kiemeney, Lambertus A.L.M., N'Dow, James, Plass, Karin, Čapoun, Otakar , Soukup, Viktor, Dominguez-Escrig, Jose L., Cohen, Daniel, Palou, Joan, Gontero, Paolo, Burger, Maximilian, Zigeuner, Richard, Mostafid, Amir Hugh, Shariat, Shahrokh F., Rouprêt, Morgan, Compérat, Eva M., Babjuk, Marko und van Rhijn, Bas W.G. (2023) Erratum to “European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel” [Eur. Urol. 79(4) (2021) 480–488]. European Urology 83 (5), e140-e141. Volltext nicht vorhanden.

Beijert, Irene J., Cheng, Liang, Liedberg, Fredrik, Plass, Karin, Williamson, Sean R., Gontero, Paolo, Ribal, Maria J., Babjuk, Marko, Black, Peter C., Kamat, Ashish M., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Masson-Lecomte, Alexandra, Rouprêt, Morgan, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Shariat, Shahrokh F., Mostafid, A. Hugh, Varma, Murali, Shen, Steven, Burger, Maximilian, Tsuzuki, Toyonori, Palou, Joan, Compérat, Eva M., Sylvester, Richard J., van der Kwast, Theo H., van Rhijn, Bas W.G. und Downes, Michelle R. (2023) International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members. European Urology Open Science 52, S. 154-165. Volltext nicht vorhanden.

Claps, Francesco , van de Kamp, Maaike W., Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F., Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Otto, Wolfgang, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Trombetta, Carlo, Eckstein, Markus , Mertens, Laura S., Burger, Maximilian, Soorojebally, Yanish, Wullich, Bernd, Bartoletti, Riccardo, Radvanyi, François, Pavan, Nicola, Sirab, Nanour, Mir, M. Carmen, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Bussani, Rossana, Allory, Yves und van Rhijn, Bas W.G. (2023) Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU International 132 (2), S. 170-180. Volltext nicht vorhanden.

Einerhand, Sarah M.H., Voskuilen, Charlotte S., van de Putte, Elies E. Fransen, Donswijk, Maarten L. , Bruining, Annemarie, van der Heijden, Michiel S., Mertens, Laura S., Hendricksen, Kees, Vegt, Erik und van Rhijn, Bas W.G. (2023) Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer. Bladder Cancer 9 (1), S. 49-57. Volltext nicht vorhanden.

Mellema, Jan-Jaap J. , van Rhijn, Bas W.G. und van der Heijden, Michiel S. (2023) Recent developments in perioperative combination therapy in muscle-invasive bladder cancer. Current Opinion in Urology 33 (5), S. 404-411. Volltext nicht vorhanden.

Richters, Anke, van Ginkel, Noor , Meijer, Richard P., Wondergem, Maurits, Schoots, Ivo, Vis, André N., Kiemeney, Lambertus A.L.M., van Rhijn, Bas W.G., Witjes, J. Alfred, Aben, Katja K.H. und Mertens, Laura S. (2023) Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle‐invasive bladder cancer: a nationwide population‐based study. BJU International 132 (4), S. 420-427. Volltext nicht vorhanden.

Mertens, Laura S. , Claps, Francesco , Mayr, Roman, Hodgson, Anjelica, Shariat, Shahrokh F., Hippe, Katrin, Neuzillet, Yann, Sanders, Joyce, Burger, Maximilian, Pouessel, Damien, Otto, Wolfgang, van der Kwast, Theo H., Lotan, Yair, Allory, Yves, Downes, Michelle R. und van Rhijn, Bas W.G. (2023) The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis. International Journal of Surgical Pathology 31 (2), S. 157-166. Volltext nicht vorhanden.

van Dorp, Jeroen, van Montfoort, Maurits L., van Dijk, Nick, Hofland, Ingrid, de Feijter, Jeantine M., Bergman, Andries M., Hendricksen, Kees, van der Poel, Henk G., van Rhijn, Bas W.G. und van der Heijden, Michiel S. (2022) A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer. Clinical Genitourinary Cancer 20 (2), e173-e179. Volltext nicht vorhanden.

Mertens, Laura S. , Claps, Francesco , Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F. , Zwarthoff, Ellen C. , Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H. , Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, Peters, Dennis, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, van der Schoot, Deric K.E., Wullich, Bernd, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanour, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Allory, Yves, Zuiverloon, Tahlita C.M. und van Rhijn, Bas W.G. (2022) Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients. Urologic Oncology: Seminars and Original Investigations 40 (3), 110.e1-110.e9. Volltext nicht vorhanden.

Stokkel, Laura E., van de Kamp, Maaike W., Schaake, Eva E., Boellaard, Thierry Nicolas, Hendricksen, Kees, van Rhijn, Bas W.G. und Mertens, Laura S. (2022) Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer. Urologia Internationalis 106 (8), S. 840-847. Volltext nicht vorhanden.

Sylvester, Richard J. , Rodríguez, Oscar, Hernández, Virginia, Turturica, Diana, Bauerová, Lenka, Bruins, Harman Max, Bründl, Johannes, van der Kwast, Theo H., Brisuda, Antonin, Rubio-Briones, José, Seles, Maximilian, Hentschel, Anouk E., Kusuma, Venkata R.M., Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S. , Volanis, Dimitrios, Cussenot, Olivier, Subiela Henríquez, Jose D., de la Peña, Enrique, Pisano, Francesca, Pešl, Michael, van der Heijden, Antoine G., Herdegen, Sonja, Zlotta, Alexandre R., Hacek, Jaromir, Calatrava, Ana, Mannweiler, Sebastian, Bosschieter, Judith, Ashabere, David, Haitel, Andrea, Côté, Jean-François, El Sheikh, Soha , Lunelli, Luca, Algaba, Ferran, Alemany, Isabel, Soria, Francesco, Runneboom, Willemien, Breyer, Johannes, Nieuwenhuijzen, Jakko A., Llorente, Carlos, Molinaro, Luca, Hulsbergen-van de Kaa, Christina A., Evert, Matthias, Kiemeney, Lambertus A.L.M., N’Dow, James, Plass, Karin, Čapoun, Otakar, Soukup, Viktor, Dominguez-Escrig, Jose L., Cohen, Daniel, Palou, Joan, Gontero, Paolo, Burger, Maximilian, Zigeuner, Richard, Mostafid, Amir Hugh, Shariat, Shahrokh F., Rouprêt, Morgan, Compérat, Eva M., Babjuk, Marko und van Rhijn, Bas W.G. (2021) European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. European Urology 79 (4), S. 480-488. Volltext nicht vorhanden.

van Rhijn, Bas W.G., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Hernández, Virginia, Čapoun, Otakar, Bruins, H. Maxim, Cohen, Daniel, Rouprêt, Morgan, Shariat, Shahrokh F., Mostafid, A. Hugh, Zigeuner, Richard, Dominguez-Escrig, Jose L., Burger, Maximilian, Soukup, Viktor, Gontero, Paolo, Palou, Joan, van der Kwast, Theo H., Babjuk, Marko, Sylvester, Richard J., van Rhijn, Bas W.G., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Plass, Karin, Rodríguez, Oscar, Subiela Henríquez, Jose D., Hernández, Virginia, de la Peña, Enrique, Alemany, Isabel, Turturica, Diana, Pisano, Francesca, Soria, Francesco, Čapoun, Otakar, Bauerová, Lenka, Pešl, Michael, Bruins, H. Maxim, Runneboom, Willemien, Herdegen, Sonja, Breyer, Johannes, Brisuda, Antonin, Calatrava, Ana, Rubio-Briones, José, Seles, Maximilian, Mannweiler, Sebastian, Bosschieter, Judith, Kusuma, Venkata R.M., Ashabere, David, Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S., Cohen, Daniel, Lunelli, Luca, Cussenot, Olivier, El Sheikh, Soha, Volanis, Dimitrios, Côté, Jean-François, Rouprêt, Morgan, Haitel, Andrea, Shariat, Shahrokh F., Mostafid, A. Hugh, Nieuwenhuijzen, Jakko A., Zigeuner, Richard, Dominguez-Escrig, Jose L., Hacek, Jaromir, Zlotta, Alexandre R., Burger, Maximilian, Evert, Matthias, Hulsbergen - van de Kaa, Christina A., van der Heijden, Antoine G., Kiemeney, Lambertus A.L.M., Soukup, Viktor, Molinaro, Luca, Gontero, Paolo, Llorente, Carlos, Algaba, Ferran, Palou, Joan, N’Dow, James, van der Kwast, Theo H., Babjuk, Marko und Sylvester, Richard J. (2021) Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study. European Urology Oncology 4 (2), S. 182-191. Volltext nicht vorhanden.

Albers, Leonore F., Tillier, Corinne N., van Muilekom, Erik, van Werkhoven, Erik, Elzevier, Henk W., van Rhijn, Bas W.G., van der Poel, Henk G. und Hendricksen, Kees (2021) Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study. The Journal of Sexual Medicine 18 (2), S. 339-346. Volltext nicht vorhanden.

Stokkel, Laura E., Stokkel, Marcel P.M, Donswijk, Maarten L., Lahaye, Max J., Bekers, Elise M., van Rhijn, Bas W.G. und Mertens, Laura S. (2021) The Diagnostic Value of FDG-PET/CT for Urachal Cancer. Clinical Genitourinary Cancer 19 (5), S. 373-380. Volltext nicht vorhanden.

Haas, Maximilian, Huber, Toni, Pickl, Christoph, van Rhijn, Bas W.G., Gužvić, Miodrag, Gierth, Michael, Breyer, Johannes, Burger, Maximilian und Mayr, Roman (2021) The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer. European Journal of Surgical Oncology 47 (5), S. 1163-1171. Volltext nicht vorhanden.

Stokkel, Laura E., van Montfoort, Maurits L., van Boven, Hester H., Mertens, Laura S. und van Rhijn, Bas W.G. (2021) Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra. European Urology Open Science 33, S. 56-60. Volltext nicht vorhanden.

van Rhijn, Bas W.G., Mertens, Laura S., Mayr, Roman, Bostrom, Peter J., Real, Francisco X. , Zwarthoff, Ellen C., Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H., Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, van der Heijden, Michiel S., Jewett, Michael A.S., Marquez, Mirari, Stoehr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, Roshani, Hossain, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanor, Pouessel, Damien, Wullich, Bernd, van der Kwast, Theo H., Malats, Núria, Hartmann, Arndt, Allory, Yves und Zuiverloon, Tahlita C.M. (2020) FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†. European Urology 78 (5), S. 682-687. Volltext nicht vorhanden.

Voskuilen, Charlotte S., van de Kamp, Maaike W., Schuring, Nannet, Mertens, Laura S., Noordzij, Arjen, Pos, Floris, van Rhijn, Bas W.G., van der Heijden, Michiel S. und Schaake, Eva E. (2020) Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil. Radiotherapy and Oncology 150, S. 275-280. Volltext nicht vorhanden.

Hodgson, Anjelica, van Rhijn, Bas W.G., Kim, Sung Sun, Ding, Colleen, Saleeb, Rola , Vesprini, Danny, Liu, Stanley K., Yousef, George M., van der Kwast, Theodorus H., Xu, Bin und Downes, Michelle R. (2020) Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. Pathology - Research and Practice 216 (11), S. 153186. Volltext nicht vorhanden.

Voskuilen, Charlotte S., Bosschieter, Judith, van Werkhoven, Erik, Hendricksen, Kees, Vis, André N., Witteveen, Thelma, Pieters, Bradley R. , Burger, Max, Bex, Axel, van der Poel, Henk G., Moonen, Luc M., Horenblas, Simon, Nieuwenhuijzen, Jakko A. und van Rhijn, Bas W.G. (2019) Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer. Radiotherapy and Oncology 141, S. 130-136. Volltext nicht vorhanden.